SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : Alternative Medicine/Health -- Ignore unavailable to you. Want to Upgrade?

To: LLCF who wrote (82)12/20/1999 2:06:00 PM
From: scaram(o)uche  Respond to of 357
 
>> just showing my frustration with the rigid confines with which much of todays U.S. medical community seems to operate <<

I know that Dave. Just joking, and in complete agreement with the sentiment. If a disorder has a genetic component, it doesn't invalidate your thoughts in the least. The question regarding frequency of diagnosis stands, as do concerns about behavioral and environmental influences.



To: LLCF who wrote (82)1/20/2000 5:46:00 PM
From: Gordon A. Langston  Read Replies (1) | Respond to of 357
 
Dave

In case you didn't catch this one.

Avandia, a diabetes drug (SKB) hard on the liver of two patients.

Robert Diamond of the U. of Penn said in the annals of Internal Medicine that both patients showed signs of liver poisoning , and recovered after they stopped taking the drug.

It is related to Rezulin another diabetes drug that has been restricted after it was shown to cause liver damage in some patients.

Regards
Gordon


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News